COVID-19-Related EUAs To Remain In Effect Following Expiration of Public Health Emergency

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

COVID-19-Related EUAs To Remain In Effect Following Expiration of Public Health Emergency

Dennis Tosh

March 23, 2023 at 10:48 AM EST

Emergency use authorizations (EUAs) issued by the FDA for devices and other medical products related to COVID-19 will remain in effect beyond the planned May 11 expiration of the COVID-19 public health emergency, the Department of Health and Human Services (HHS) has determined. Effective March 15, HHS Secretary Xavier Becerra amended the Feb. 4, 2020, COVID-19 public health e... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

COVID-19-Related EUAs To Remain In Effect Following Expiration of Public Health Emergency

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT